Understand the source comparison
Dihexa Peptide Comparison: Storage Stability Across Research Compounds
Different peptides used in nootropic and metabolic research show widely varying temperature sensitivity. This comparison positions Dihexa within the broader peptide storage landscape, so researchers can calibrate their handling protocols appropriately. Dihexa
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Different peptides used in nootropic and metabolic research show widely varying temperature sensitivity. This comparison positions Dihexa within the broader peptide storage landscape, so researchers can calibrate their handling protocols appropriately.
- Dihexa
- −20°C, 12–24 months
- 2–8°C, 28 days
- 48–72 hours before 50% degradation
- Not recommended. Ice crystals disrupt structure
- Moderate stability; requires refrigeration post-reconstitution but tolerates brief ambient exposure
- BPC-157
- −20°C, 24 months
- 2–8°C, 60 days
- 7–10 days at 20–25°C
- Tolerates freezing with minimal loss
- High stability; one of the most temperature-resilient peptides in research use
- Cerebrolysin
- 2–8°C (pre-filled ampules)
- Use immediately upon opening
- Not stable; degrades within hours
- Not recommended
- Low stability; must be refrigerated continuously and used same-day once opened
- Semax
- −20°C, 18 months
- 2–8°C, 30 days
- 2–4 days at room temperature
- Moderate stability; similar profile to Dihexa
- Thymosin Alpha-1
- 48 hours before noticeable loss
- Moderate stability; standard peptide handling applies
- Semaglutide (GLP-1)
- 2–8°C, 28–56 days (dose-dependent)
- 24–48 hours in pre-filled pens
- Moderate to high stability; pharmaceutical formulations include stabilizers
- Dihexa sits in the middle of the peptide stability spectrum. It is not as fragile as Cerebrolysin, which requires continuous cold chain from manufacture to administration, but it is not as forgiving as BPC-157, which can tolerate multi-day lapses in refrigeration without complete loss of bioactivity. For practical research purposes, treat Dihexa as requiring strict refrigeration after reconstitution. Plan your administration schedule so you do not depend on the peptide remaining stable outside the fridge for more than a few hours.
- The small-batch synthesis process at Real Peptides ensures each vial of Dihexa is produced with exact amino acid sequencing and verified purity before shipping. That precision means nothing if the peptide degrades in your refrigerator due to improper post-receipt handling. Quality at synthesis must be matched by quality in storage.